Cited by 31Retinal Diseases and TreatmentsComplement system in diseasesRetinal Development and Disorders

Rare complement factor I variants associated with reduced macular thickness and age-related macular degeneration in the UK Biobank

Open access
Tzoumas, Nikolaos, Kavanagh, David, Cordell, Heather J, Lotery, Andrew J, Patel, Praveen J, Steel, David H·2022·Human Molecular Genetics

Abstract

To evaluate potential diagnostic and therapeutic biomarkers for age-related macular degeneration (AMD), we identified 8433 UK Biobank participants with rare complement Factor I gene (CFI) variants, 579 with optical coherence tomography-derived macular thickness data. We stratified these variants by predicted gene expression and measured their association with retinal pigment epithelium-Bruch’s membrane (RPE-BM) complex and retinal thicknesses at nine macular subfields, as well as AMD risk, using multivariable regression models adjusted for the common complement Factor H gene (CFH) p.Y402H and age-related maculopathy susceptibility protein 2 gene (ARMS2) p.A69S risk genotypes. CFI variants associated with low Factor I levels predicted a thinner mean RPE-BM (95% confidence interval [CI] −1.66 to −0.37 μm, P = 0.002) and retina (95% CI −5.88 to −0.13 μm, P = 0.04) and a higher AMD risk (odds ratio [OR] = 2.26, 95% CI 1.56 to 3.27, P < 0.001). CFI variants associated with normal Factor I levels did not impact mean RPE-BM/retinal thickness (P = 0.28; P = 0.99) or AMD risk (P = 0.97). CFH p.Y402H was associated with a thinner RPE-BM (95% CI −0.31 to −0.18 μm, P < 0.001 heterozygous; 95% CI −0.62 to −0.42 μm, P < 0.001 homozygous) and retina (95% CI −0.73 to −0.12 μm, P = 0.007 heterozygous; 95% CI −1.08 to −0.21 μm, P = 0.004 homozygous). ARMS2 p.A69S did not influence RPE-BM (P = 0.80 heterozygous; P = 0.12 homozygous) or retinal thickness (P = 0.75 heterozygous; P = 0.07 homozygous). p.Y402H and p.A69S exhibited a significant allele–dose response with AMD risk. Thus, CFI rare variants associated with low Factor I levels are robust predictors of reduced macular thickness and AMD. The observed association between macular thickness and CFH p.Y402H, but not ARMS2 p.A69S, highlights the importance of complement dysregulation in early pathogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddac060

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some studies have shown that FB has a pro-angiogenic effect mediated through increased VEGF and VEGFR2 expression by endothelial cells in mouse models of laser-induced CNV and retinal hypoxia.

    “Some studies have shown that FB has a pro-angiogenic effect mediated through increased VEGF and VEGFR2 expression by endothelial cells in mouse models of laser-induced CNV and retinal hypoxia [81,153,171].”
  • Our recent study of the UK Biobank found that the common at-risk FH genotype (CFH p.Y402H) and different rare FI variants were associated with reduced RPE-BrM complex thickness in healthy participants, suggesting that complement overactivation may have a negative impact on the function and viability of RPE cells.

    “In addition, our recent study of the UK Biobank, the largest repository of retinal imaging data to date, found that the common at-risk FH genotype (CFH p.Y402H) and different rare FI variants were associated with reduced RPE–BrM complex thickness in healthy participants, suggesting that complement overactivation may have a negative impact on the function and viability of RPE cells [81].”
  • Patients with genetic abnormalities in the complement system tend to only develop overt disease in one organ (such as AMD, C3 glomerulopathy, or atypical haemolytic uraemic syndrome), even in the presence of rare, pathogenic variants or haploinsufficiency of FH and FI.

    “patients with genetic abnormalities in the complement system tend to only develop overt disease in one organ (such as AMD, C3 glomerulopathy, or atypical haemolytic uraemic syndrome), even in the presence of rare, pathogenic variants or haploinsufficiency of FH and FI [81,220,221,222,223].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tzoumas, N., Kavanagh, D., Cordell, H. J., Lotery, A. J., Patel, P. J., & Steel, D. H.
Affiliations
  • Newcastle University (GB)
  • Royal Victoria Infirmary (GB)
  • University of Southampton (GB)
  • Moorfields Eye Hospital NHS Foundation Trust (GB)
  • Sunderland Eye Infirmary (GB)
Corresponding author
Tzoumas, Nikolaos
Venue
Human Molecular Genetics
Published
2022-03-14
Volume
31
Issue
16
Pages
2678-2692
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W4220805595
Cited by
31
References
51
Citations by year
2026: 3 · 2025: 7 · 2024: 12 · 2023: 5 · 2022: 4
FWCI
6.26
Type
journal article
Language
en
Open access
Locations
  • Human Molecular Genetics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity) (cc-by)
Funders
  • National Institute for Health and Care Research (NF-SI-0515-10020, NF-SI-0507-10094)
  • Medical Research Council (MC_PC_17228)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
Keywords
age-related macular degeneration, complement factor I, macular thickness, retinal thickness, rare variants, biomarkers, complement system, UK Biobank, optical coherence tomography, genetic risk factors
MeSH terms
Fibrinogen, Genotype, United Kingdom, Humans, Macular Degeneration, Complement Factor H, Complement Factor I, Biological Specimen Banks, Polymorphism, Single Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review